StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SABS

SAB Biotherapeutics, Inc.

SABSW Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.02
-0.00 -15.00%

Key statistics

from XBRL data in SEC filings
Market cap
$1.30M
Revenue (TTM)
$2.78M
Net income (TTM)
-$398K
EPS (TTM)
$-0.58
P/E ratio
Dividend yield
Free cash flow
-$45.7M
Cash
$20.5M
Total assets
$248M
Gross margin
52-week range
$0.02 – $0.02

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 7, 2026 8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Entered a material agreement May 4, 2026 8-K Regulation FD disclosure Apr 22, 2026 8-K Entered a material agreement; Other events Mar 19, 2026 8-K Regulation FD disclosure; Other events Mar 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Director or officer change; Regulation FD disclosure Jan 7, 2026 8-K Other events Dec 29, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Sep 30, 2025 8-K Director or officer change; Shareholder vote results Sep 26, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Jul 21, 2025 8-K Shareholder vote results Jul 17, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Entered a material agreement; Completed an acquisition or disposition Feb 5, 2025 8-K Other events Jan 28, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Regulation FD disclosure Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change; Regulation FD disclosure Jul 31, 2024 8-K Shareholder vote results Jun 27, 2024 8-K Director or officer change; Regulation FD disclosure May 31, 2024 8-K Other events May 21, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 8-K Director or officer change; Regulation FD disclosure May 8, 2024 8-K Regulation FD disclosure Apr 15, 2024 8-K Results of operations (earnings release) Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Entered a material agreement; Director or officer change Mar 8, 2024 8-K Director or officer change; Regulation FD disclosure Feb 2, 2024 8-K Entered a material agreement Jan 26, 2024 8-K Other events Jan 25, 2024 8-K Regulation FD disclosure Jan 19, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Jan 3, 2024 8-K Regulation FD disclosure Nov 29, 2023